Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis

Authors: Paola Scognamiglio, Giacomina Chiaradia, Gabriella De Carli, Massimo Giuliani, Claudio Maria Mastroianni, Stefano Aviani Barbacci, Anna Rita Buonomini, Susanna Grisetti, Alessandro Sampaolesi, Angela Corpolongo, Nicoletta Orchi, Vincenzo Puro, Giuseppe Ippolito, Enrico Girardi, for the SENDIH Study Group

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

The aim of our work was to evaluate the potential impact of the European policy of testing for HIV all individuals presenting with an indicator disease, to prevent late diagnosis of HIV. We report on a retrospective analysis among individuals diagnosed with HIV to assess whether a history of certain diseases prior to HIV diagnosis was associated with the chance of presenting late for care, and to estimate the proportion of individuals presenting late who could have been diagnosed earlier if tested when the indicator disease was diagnosed.

Methods

We studied a large cohort of individuals newly diagnosed with HIV infection in 13 counselling and testing sites in the Lazio Region, Italy (01/01/2004-30/04/2009). Considered indicator diseases were: viral hepatitis infection (HBV/HCV), sexually transmitted infections, seborrhoeic dermatitis and tuberculosis. Logistic regression analysis was performed to estimate association of occurrence of at least one indicator disease with late HIV diagnosis.

Results

In our analysis, the prevalence of late HIV diagnosis was 51.3% (890/1735). Individuals reporting at least one indicator disease before HIV diagnosis (29% of the study population) had a lower risk of late diagnosis (OR = 0.7; 95%CI: 0.5-0.8) compared to those who did not report a previous indicator disease. 52/890 (5.8%) late presenters were probably already infected at the time the indicator disease was diagnosed, a median of 22.6 months before HIV diagnosis.

Conclusions

Our data suggest that testing for HIV following diagnosis of an indicator disease significantly decreases the probability of late HIV diagnosis. Moreover, for 5.5% of late HIV presenters, diagnosis could have been anticipated if they had been tested when an HIV indicator disease was diagnosed.
However, this strategy for enhancing early HIV diagnosis needs to be complemented by client-centred interventions that aim to increase awareness in people who do not perceive themselves as being at risk for HIV.
Appendix
Available only for authorised users
Literature
1.
go back to reference Antiretroviral Therapy Cohort Collaboration: Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008, 372: 293-299.CrossRef Antiretroviral Therapy Cohort Collaboration: Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008, 372: 293-299.CrossRef
2.
go back to reference Hamers FF, Phillips AN: Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med. 2008, 9 (Suppl 2): 6-12.CrossRefPubMed Hamers FF, Phillips AN: Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med. 2008, 9 (Suppl 2): 6-12.CrossRefPubMed
3.
go back to reference Johnson M, Sabin C, Girardi E: Definition and epidemiology of late presentation in Europe. Antivir Ther. 2010, 15 (Suppl 1): 3-8. 10.3851/IMP1522.CrossRefPubMed Johnson M, Sabin C, Girardi E: Definition and epidemiology of late presentation in Europe. Antivir Ther. 2010, 15 (Suppl 1): 3-8. 10.3851/IMP1522.CrossRefPubMed
4.
go back to reference Likatavicius G, Van de Laar MJ: HIV and AIDS in the European Union, 2009. Euro Surveill. 2010, 15 (48): 19737-PubMed Likatavicius G, Van de Laar MJ: HIV and AIDS in the European Union, 2009. Euro Surveill. 2010, 15 (48): 19737-PubMed
5.
go back to reference Centers for Disease Control and Prevention (CDC): Persons tested for HIV–United States, 2006. MMWR Morb Mortal Wkly Rep. 2008, 57: 845-849. Centers for Disease Control and Prevention (CDC): Persons tested for HIV–United States, 2006. MMWR Morb Mortal Wkly Rep. 2008, 57: 845-849.
6.
go back to reference Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Justice AC, Gebo KA, Eron JJ, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Calzavara LM, Deeks SG, Martin JN, Rachlis AR, Napravnik S, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Kushel M, Goedert JJ, McKaig RG, Van Rompaey SE, et al: Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis. 2010, 50: 1512-1520. 10.1086/652650.CrossRefPubMedPubMedCentral Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Justice AC, Gebo KA, Eron JJ, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Calzavara LM, Deeks SG, Martin JN, Rachlis AR, Napravnik S, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Kushel M, Goedert JJ, McKaig RG, Van Rompaey SE, et al: Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis. 2010, 50: 1512-1520. 10.1086/652650.CrossRefPubMedPubMedCentral
7.
go back to reference Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, Clark JE, Centers for Disease Control and Prevention (CDC): Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006, 55: 1-17.PubMed Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, Clark JE, Centers for Disease Control and Prevention (CDC): Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006, 55: 1-17.PubMed
8.
go back to reference Merchant RC, Waxman MJ: HIV screening in health care settings: some progress, even more questions. JAMA. 2010, 304: 348-349. 10.1001/jama.2010.996.CrossRefPubMed Merchant RC, Waxman MJ: HIV screening in health care settings: some progress, even more questions. JAMA. 2010, 304: 348-349. 10.1001/jama.2010.996.CrossRefPubMed
9.
go back to reference Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S, Leon A, Begovac J, Brinkman K, Zangerle R, Grzeszczuk A, Vassilenko A, Hadziosmanovic V, Krasnov M, Sönnerborg A, Clumeck N, Gatell J, Gazzard B, Monforte A, Rockstroh J, Lundgren JD: Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLoS One. 2013, 8: e52845-10.1371/journal.pone.0052845.CrossRefPubMedPubMedCentral Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S, Leon A, Begovac J, Brinkman K, Zangerle R, Grzeszczuk A, Vassilenko A, Hadziosmanovic V, Krasnov M, Sönnerborg A, Clumeck N, Gatell J, Gazzard B, Monforte A, Rockstroh J, Lundgren JD: Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLoS One. 2013, 8: e52845-10.1371/journal.pone.0052845.CrossRefPubMedPubMedCentral
10.
go back to reference Rayment M, Thornton A, Mandalia S, Elam G, Atkins M, Jones R, Nardone A, Roberts P, Tenant-Flowers M, Anderson J, Sullivan AK, HINTS Study Group: HIV testing in non-traditional settings-the HINTS study: a multi-centre observational study of feasibility and acceptability. PLoS One. 2012, 7: e39530-10.1371/journal.pone.0039530.CrossRefPubMedPubMedCentral Rayment M, Thornton A, Mandalia S, Elam G, Atkins M, Jones R, Nardone A, Roberts P, Tenant-Flowers M, Anderson J, Sullivan AK, HINTS Study Group: HIV testing in non-traditional settings-the HINTS study: a multi-centre observational study of feasibility and acceptability. PLoS One. 2012, 7: e39530-10.1371/journal.pone.0039530.CrossRefPubMedPubMedCentral
11.
go back to reference Gazzard B, Clumeck N, D’Arminio Monforte A, Lundgren JD: Indicator disease-guided testing for HIV–the next step for Europe?. HIV Med. 2008, 9 (Suppl. 2): 34-40.CrossRefPubMed Gazzard B, Clumeck N, D’Arminio Monforte A, Lundgren JD: Indicator disease-guided testing for HIV–the next step for Europe?. HIV Med. 2008, 9 (Suppl. 2): 34-40.CrossRefPubMed
13.
go back to reference Orchi N, Balzano R, Scognamiglio P, Navarra A, De Carli G, Elia P, Grisetti S, Sampaolesi A, Giuliani M, De Filippis A, Puro V, Ippolito G, Girardi E, SENDIH Group: Ageing with HIV: newly diagnosed older adults in Italy. AIDS Care. 2008, 20: 419-425. 10.1080/09540120701867073.CrossRefPubMed Orchi N, Balzano R, Scognamiglio P, Navarra A, De Carli G, Elia P, Grisetti S, Sampaolesi A, Giuliani M, De Filippis A, Puro V, Ippolito G, Girardi E, SENDIH Group: Ageing with HIV: newly diagnosed older adults in Italy. AIDS Care. 2008, 20: 419-425. 10.1080/09540120701867073.CrossRefPubMed
14.
go back to reference Mammone A, Pezzotti P, Angeletti C, Orchi N, Carboni A, Navarra A, Sciarrone MR, Sias C, Puro V, Guasticchi G, Ippolito G, Borgia P, Girardi E, SENDIH Study Group: HIV incidence estimate combining HIV/AIDS surveillance, testing history information and HIV test to identify recent infections in Lazio, Italy. BMC Infect Dis. 2012, 12: 65-10.1186/1471-2334-12-65.CrossRefPubMedPubMedCentral Mammone A, Pezzotti P, Angeletti C, Orchi N, Carboni A, Navarra A, Sciarrone MR, Sias C, Puro V, Guasticchi G, Ippolito G, Borgia P, Girardi E, SENDIH Study Group: HIV incidence estimate combining HIV/AIDS surveillance, testing history information and HIV test to identify recent infections in Lazio, Italy. BMC Infect Dis. 2012, 12: 65-10.1186/1471-2334-12-65.CrossRefPubMedPubMedCentral
15.
go back to reference Harris T, Panaro L, Phypers M, Choudhri Y, Archibald CP: HIV testing among Canadian tuberculosis cases from 1997 to 1998. Can J Infect Dis Med Microbiol. 2006, 17: 165-168.PubMedPubMedCentral Harris T, Panaro L, Phypers M, Choudhri Y, Archibald CP: HIV testing among Canadian tuberculosis cases from 1997 to 1998. Can J Infect Dis Med Microbiol. 2006, 17: 165-168.PubMedPubMedCentral
16.
go back to reference Rodger AJ, Story A, Fox Z, Hayward A, London Tuberculosis Nurses Network: HIV prevalence and testing practices among tuberculosis cases in London: a missed opportunity for HIV diagnosis?. Thorax. 2010, 65: 63-69. 10.1136/thx.2009.122754.CrossRefPubMed Rodger AJ, Story A, Fox Z, Hayward A, London Tuberculosis Nurses Network: HIV prevalence and testing practices among tuberculosis cases in London: a missed opportunity for HIV diagnosis?. Thorax. 2010, 65: 63-69. 10.1136/thx.2009.122754.CrossRefPubMed
17.
go back to reference Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, Girardi E, Johnson M, Kirk O, Lundgren J, Mocroft A, D'Arminio Monforte A, Phillips A, Raben D, Rockstroh JK, Sabin C, Sönnerborg A, De Wolf F, European Late Presenter Consensus Working Group: Late presentation of HIV infection: a consensus definition. HIV Med. 2011, 12: 61-64.CrossRefPubMed Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, Girardi E, Johnson M, Kirk O, Lundgren J, Mocroft A, D'Arminio Monforte A, Phillips A, Raben D, Rockstroh JK, Sabin C, Sönnerborg A, De Wolf F, European Late Presenter Consensus Working Group: Late presentation of HIV infection: a consensus definition. HIV Med. 2011, 12: 61-64.CrossRefPubMed
18.
go back to reference Lodi S, Phillips A, Touloumi G, Geskus R, Meyer L, Thiébaut R, Pantazis N, Amo JD, Johnson AM, Babiker A, Porter K, CASCADE Collaboration in EuroCoord: Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm3: assessment of need following changes in treatment guidelines. Clin Infect Dis. 2011, 53: 817-825. 10.1093/cid/cir494.CrossRefPubMed Lodi S, Phillips A, Touloumi G, Geskus R, Meyer L, Thiébaut R, Pantazis N, Amo JD, Johnson AM, Babiker A, Porter K, CASCADE Collaboration in EuroCoord: Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm3: assessment of need following changes in treatment guidelines. Clin Infect Dis. 2011, 53: 817-825. 10.1093/cid/cir494.CrossRefPubMed
19.
go back to reference Adler A, Mounier-Jack S, Coker RJ: Late diagnosis of HIV in Europe: definitional and public health challenges. AIDS Care. 2009, 21: 284-293. 10.1080/09540120802183537.CrossRefPubMed Adler A, Mounier-Jack S, Coker RJ: Late diagnosis of HIV in Europe: definitional and public health challenges. AIDS Care. 2009, 21: 284-293. 10.1080/09540120802183537.CrossRefPubMed
20.
go back to reference Borghi V, Girardi E, Bellelli S, Angeletti C, Mussini C, Porter K, Esposito R: Late presenters in an HIV surveillance system in Italy during the period 1992–2006. J Acquir Immune Defic Syndr. 2008, 49: 282-286. 10.1097/QAI.0b013e318186eabc.CrossRefPubMed Borghi V, Girardi E, Bellelli S, Angeletti C, Mussini C, Porter K, Esposito R: Late presenters in an HIV surveillance system in Italy during the period 1992–2006. J Acquir Immune Defic Syndr. 2008, 49: 282-286. 10.1097/QAI.0b013e318186eabc.CrossRefPubMed
21.
go back to reference Castilla J, Sobrino P, de la Fuente L, Noguer I, Guerra L, Parras F: Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS. 2002, 16: 1945-1951. 10.1097/00002030-200209270-00012.CrossRefPubMed Castilla J, Sobrino P, de la Fuente L, Noguer I, Guerra L, Parras F: Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS. 2002, 16: 1945-1951. 10.1097/00002030-200209270-00012.CrossRefPubMed
22.
go back to reference Delpierre C, Dray-Spira R, Cuzin L, Marchou B, Massip P, Lang T, Lert F, VESPA Study Group: Correlates of late HIV diagnosis: implications for testing policy. Int J STD AIDS. 2007, 18: 312-317. 10.1258/095646207780749709.CrossRefPubMedPubMedCentral Delpierre C, Dray-Spira R, Cuzin L, Marchou B, Massip P, Lang T, Lert F, VESPA Study Group: Correlates of late HIV diagnosis: implications for testing policy. Int J STD AIDS. 2007, 18: 312-317. 10.1258/095646207780749709.CrossRefPubMedPubMedCentral
23.
go back to reference Klein D, Hurley LB, Merrill D, Quesenberry CP, for Consortium for HIV/AIDS Interregional Research: Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr. 2003, 32: 143-152. 10.1097/00126334-200302010-00005.CrossRefPubMed Klein D, Hurley LB, Merrill D, Quesenberry CP, for Consortium for HIV/AIDS Interregional Research: Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr. 2003, 32: 143-152. 10.1097/00126334-200302010-00005.CrossRefPubMed
24.
go back to reference Ellis S, Curtis H, Ong EL, British HIV Association (BHIVA); BHIVA Clinical Audit and Standards sub-committee: HIV diagnoses and missed opportunities. Results of the British HIV Association (BHIVA) National Audit 2010. Clin Med. 2012, 12: 430-434. 10.7861/clinmedicine.12-5-430.CrossRef Ellis S, Curtis H, Ong EL, British HIV Association (BHIVA); BHIVA Clinical Audit and Standards sub-committee: HIV diagnoses and missed opportunities. Results of the British HIV Association (BHIVA) National Audit 2010. Clin Med. 2012, 12: 430-434. 10.7861/clinmedicine.12-5-430.CrossRef
25.
go back to reference Lo YC, Wu PY, Hsieh CY, Chen MY, Sheng WH, Hsieh SM, Sun HY, Liu WC, Hung CC, Chang SC: Late diagnosis of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: role of socio-behavioral factors and medical encounters. J Formos Med Assoc. 2011, 110: 306-315. 10.1016/S0929-6646(11)60046-6.CrossRefPubMed Lo YC, Wu PY, Hsieh CY, Chen MY, Sheng WH, Hsieh SM, Sun HY, Liu WC, Hung CC, Chang SC: Late diagnosis of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: role of socio-behavioral factors and medical encounters. J Formos Med Assoc. 2011, 110: 306-315. 10.1016/S0929-6646(11)60046-6.CrossRefPubMed
26.
go back to reference Duffus WA, Weis K, Kettinger L, Stephens T, Albrecht H, Gibson JJ: Risk-based HIV testing in South Carolina health care settings failed to identify the majority of infected individuals. AIDS Patient Care STDS. 2009, 23: 339-345. 10.1089/apc.2008.0193.CrossRefPubMedPubMedCentral Duffus WA, Weis K, Kettinger L, Stephens T, Albrecht H, Gibson JJ: Risk-based HIV testing in South Carolina health care settings failed to identify the majority of infected individuals. AIDS Patient Care STDS. 2009, 23: 339-345. 10.1089/apc.2008.0193.CrossRefPubMedPubMedCentral
27.
go back to reference Jenkins TC, Gardner EM, Thrun MW, Cohn DL, Burman WJ: Risk based human immunodeficiency virus (HIV) testing fails to detect the majority of HIV-infected persons in medical care settings. Sex Transm Dis. 2006, 33: 329-333. 10.1097/01.olq.0000194617.91454.3f.CrossRefPubMed Jenkins TC, Gardner EM, Thrun MW, Cohn DL, Burman WJ: Risk based human immunodeficiency virus (HIV) testing fails to detect the majority of HIV-infected persons in medical care settings. Sex Transm Dis. 2006, 33: 329-333. 10.1097/01.olq.0000194617.91454.3f.CrossRefPubMed
28.
go back to reference Liddicoat RV, Horton NJ, Urban R, Maier E, Christiansen D, Samet JH: Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med. 2004, 19: 349-356. 10.1111/j.1525-1497.2004.21251.x.CrossRefPubMedPubMedCentral Liddicoat RV, Horton NJ, Urban R, Maier E, Christiansen D, Samet JH: Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med. 2004, 19: 349-356. 10.1111/j.1525-1497.2004.21251.x.CrossRefPubMedPubMedCentral
29.
go back to reference Antonucci G, Girardi E, Raviglione MC, Ippolito G: Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA. 1995, 274: 143-148. 10.1001/jama.1995.03530020061033.CrossRefPubMed Antonucci G, Girardi E, Raviglione MC, Ippolito G: Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA. 1995, 274: 143-148. 10.1001/jama.1995.03530020061033.CrossRefPubMed
31.
go back to reference Nnoruka EN, Chukwuka JC, Anisuiba B: Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression. Int J Dermatol. 2007, 46 (Suppl.2): 14-18.CrossRefPubMed Nnoruka EN, Chukwuka JC, Anisuiba B: Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression. Int J Dermatol. 2007, 46 (Suppl.2): 14-18.CrossRefPubMed
32.
go back to reference Harrison KM, Kajese T, Hall HI, Song R: Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep. 2008, 123: 618-627.PubMedPubMedCentral Harrison KM, Kajese T, Hall HI, Song R: Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep. 2008, 123: 618-627.PubMedPubMedCentral
33.
go back to reference Krain A, Wisnivesky JP, Garland E, McGinn T: Prevalence of human immunodeficiency virus testing in individuals with hepatitis B and C infection. Mayo Clin Proc. 2004, 79: 51-56. 10.4065/79.1.51.CrossRefPubMed Krain A, Wisnivesky JP, Garland E, McGinn T: Prevalence of human immunodeficiency virus testing in individuals with hepatitis B and C infection. Mayo Clin Proc. 2004, 79: 51-56. 10.4065/79.1.51.CrossRefPubMed
34.
go back to reference Søgaard OS, Lohse N, Østergaard L, Kronborg G, Røge B, Gerstoft J, Sørensen HT, Obel N: Morbidity and risk of subsequent diagnosis of HIV: a population based case control study identifying indicator diseases for HIV infection. PLoS One. 2012, 7: e32538-10.1371/journal.pone.0032538.CrossRefPubMedPubMedCentral Søgaard OS, Lohse N, Østergaard L, Kronborg G, Røge B, Gerstoft J, Sørensen HT, Obel N: Morbidity and risk of subsequent diagnosis of HIV: a population based case control study identifying indicator diseases for HIV infection. PLoS One. 2012, 7: e32538-10.1371/journal.pone.0032538.CrossRefPubMedPubMedCentral
Metadata
Title
The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis
Authors
Paola Scognamiglio
Giacomina Chiaradia
Gabriella De Carli
Massimo Giuliani
Claudio Maria Mastroianni
Stefano Aviani Barbacci
Anna Rita Buonomini
Susanna Grisetti
Alessandro Sampaolesi
Angela Corpolongo
Nicoletta Orchi
Vincenzo Puro
Giuseppe Ippolito
Enrico Girardi
for the SENDIH Study Group
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-473

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.